Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FCE-29642A: a novel antiepileptic compound from Pharmacia & Upjohn

April 7, 1997

Calcium channel blockers disclosed by Warner-Lambert

April 7, 1997

Novo Nordisk claims metabotropic glutamate receptor antagonists

April 7, 1997

Shire's sustained-release carbamazepine deemed approvable by FDA

April 4, 1997

Schering-Plough claims adenosine A2a antagonists

April 4, 1997

Novo Nordisk discloses metabotropic glutamate receptor antagonists

April 4, 1997

NeoTherapeutics seeks FDA clearance for AIT-082 clinical trials

April 3, 1997

Teva's Copaxone launched in U.S.

April 3, 1997

Glaxo Wellcome discloses prodrugs of known 5-HT1-like agonist

April 3, 1997

Abbott reveals compounds for controlling synaptic transmission

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.